Use of corticosteroids and the outcome of infants with bronchopulmonary dysplasia

Mataloun, Marta M. G. B; Gibelli, Maria Augusta C; Kato, Ana V; Vaz, Flávio Adolfo Costa; Leone, Cléa Rodrigues.
Rev. Hosp. Clin. Fac. Med. Univ. Säo Paulo ; 54(6): 175-80, Nov.-Dec. 1999. graf
Artigo em Inglês | LILACS | ID: lil-260493

Documentos relacionados

  1. Systematic review of the long-term effects of postnatal corticosteroids.
  2. Trial of Dexamethasone for Chronic Subdural Hematoma.
  3. Corticosteroids for septic arthritis in children.
  4. Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews.
  5. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
  6. Bortezomib and dexamethasone, an original approach for treating multi-refractory warm autoimmune haemolytic anaemia.
  7. Comparison between "early" or "late" intravitreal injection of dexamethasone implant in branch (BRVO) or central (CRVO) retinal vein occlusion: six-months follow-up.
  8. Dexamethasone in Hospitalized Patients with Covid-19.
  9. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
  10. Dexamethasone versus Surgery for Chronic Subdural Hematoma.